表紙
市場調査レポート

メタボロミクス市場:技術別(ガスクロマトグラフィー、高速液体クロマトグラフィー、核磁気共鳴分光学、質量分析)、用途別(バイオマーカーおよび創薬、ニュートリゲノミクス)、適応別(腫瘍、心臓)の世界市場予測

Metabolomics Market by Technique, Application & by Indication- Global Forecast to 2019

発行 MarketsandMarkets 商品コード 259317
出版日 ページ情報 英文 306 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
メタボロミクス市場:技術別(ガスクロマトグラフィー、高速液体クロマトグラフィー、核磁気共鳴分光学、質量分析)、用途別(バイオマーカーおよび創薬、ニュートリゲノミクス)、適応別(腫瘍、心臓)の世界市場予測 Metabolomics Market by Technique, Application & by Indication- Global Forecast to 2019
出版日: 2014年06月26日 ページ情報: 英文 306 Pages
概要

メタボロミクスとは代謝に関する科学的プロセスを研究するもので、クロマトグラフィーや分光学、核磁気共鳴、キャピラリー電気泳動など様々な解析技術を用います。メタボロミクスは現在、医薬品業界やバイオテクノロジー業界のバイオマーカーや創薬などに広く用いられています。世界のメタボロミクス市場は大手5社が市場の75〜75%を占めているものの、多くの企業が新規に参入しているため、既存の企業との競争が激化しています。

当レポートでは、世界のメタボロミクス市場について調査し、技術別、用途別、適応別、地域別の動向、競合環境、および参入企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 プレミアムインサイト

第4章 市場概要

  • イントロダクション
    • メタボロミクスとメタボノミクス
    • メタボロミクスの概念的アプローチ
  • 市場動向
  • 促進因子
  • 阻害因子
  • 機会
  • 動向

第5章 技術投資

  • イントロダクション
  • 投資機関
  • 戦略的評価を用いた技術的投資の潜在的分野
  • 技術ロードマップ

第6章 メタボロミクス市場:技術別

  • 分離技術
    • ガスクロマトグラフィー
    • キャピラリー電気泳動
    • 高速液体クロマトグラフィー
    • 超高速液体クロマトグラフィー
  • 検出技術
    • 核磁気共鳴分光学
    • 質量分析
    • 表面質量分析

第7章 メタボロミクス市場:用途別

  • バイオマーカー創薬
  • 創薬/薬剤評価
  • 毒性検査
  • ニュートリゲノミクス
  • その他

第8章 メタボロミクス市場:適応別

  • 腫瘍
  • 心臓
  • 神経
  • その他

第9章 メタボロミクス市場:地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の諸国

第10章 競合環境

  • 新製品上市
  • 協定、提携、連携、合弁
  • 合併・買収
  • その他

第11章 企業プロファイル

  • Agilent Technologies
  • Biocrates Life Sciences AG
  • Bruker Corporation
  • Danaher Corporation
  • Human Metabolomics Technologies, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • 株式会社島津製作所
  • Thermo Fisher Scientific Inc (Life Technologies + Prionics AG)
  • Waters Corporation

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2550

In this report, the global metabolomics market is segmented based on techniques, applications, indications, and geography. Based on techniques, the metabolomics market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS), and Surface-based Mass Analysis. The application market covers biomarker discovery, drug discovery/drug assessment, toxicology testing, nutrigenomics, and others. This report also discusses the key market drivers, restraints, and opportunities in the global metabolomics market and its sub-markets.

The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent.

During the forecast period, the high performance liquid chromatography (HPLC) segment will continue to drive and dominate the metabolomics market. The large share of the HPLC segment can be attributed to its wide application in biomarker discovery. By 2018, North America will continue to drive and dominate the metabolomics market, primarily due to the presence of major metabolomics companies in the U.S. Majority of the growth in the Asia-Pacific region is primarily driven by the growing pharmaceutical and biotechnology industries in this region. Developing technologies in Japan and China for drug discovery and early diagnosis of various diseases are expected to aid the growth of the APAC metabolomics market.

The major players in the metabolomics market include Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria). Collectively, the top five players accounted for nearly 75% of the global metabolomics market in 2013.

Thermo Fisher Scientific, Inc. (U.S.) and Danaher Corporation (U.S.) are the leading players in the market which together accounted for a share of around 40% to 45% in 2013. Thermo Fisher Scientific has a diversified product portfolio, which includes a wide range of analytical products, including liquid chromatography and gas chromatography systems. The company has a strong presence in over 150 countries through its strong manufacturing and distribution facilities, which enables it to cater to a large customer base across the globe. It focuses on strengthening and streamlining its product portfolio for the metabolomics market.

Reasons to Buy the Report

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the metabolomics market. The report analyzes the metabolomics market by technique, application, and indication across all regions.
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the metabolomics market.
  • Market Development: Comprehensive information on the lucrative emerging markets by technique, application, indication, and geography.
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the metabolomics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the metabolomics market.

Table of Contents

1. Introduction

  • 1.1. Key Take-Aways
  • 1.2. Report Description
  • 1.3. Markets Covered
  • 1.4. Stakeholders
  • 1.5. Research Methodology
  • 1.6. Market Size Estimation
  • 1.7. Market crackdown and Data Triangulation
  • 1.8. Market Forecasting Model
  • 1.9. Key Data Point Taken from Secondary Sources
  • 1.10. Key Data Point Taken from Primary Sources

2. Executive Summary

3. Premium Insights

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Metabolomics Vs Metabonomics
    • 4.1.2. Conceptual Approach in Metabolomics
      • 4.1.2.1. Target Analysis
      • 4.1.2.2. Metabolite Profiling
      • 4.1.2.3. Metabolomic Fingerprinting
  • 4.2. Market Dynamics
  • 4.3. Drivers
    • 4.3.1. Research Funding and government support spurs the market growth
    • 4.3.2. Biotechnology & Pharmaceutical Sectors Drive Metabolomics Research
    • 4.3.3. Increasing demand for personalized medicine in healthcare industry
    • 4.3.4. Increased Necessity for Toxicity Technologies
  • 4.4. Restrains
    • 4.4.1. Data Processing & Analysis
    • 4.4.2. Low Adoption Rate
  • 4.5. Opportunities
    • 4.5.1. Untapped Emerging Market
    • 4.5.2. Biomarker Discovery Services
  • 4.6. Trends
    • 4.6.1. Technological Advancements
    • 4.6.2. Integration Of Research Universities With Market Players

5. Technology Investment Potential

  • 5.1. Introduction
  • 5.2. Funding Bodies
  • 5.3. Analysis of Potential Areas for Technology Investment using Strategic Evaluation
  • 5.4. Technology Roadmap

6. Metabolomics Market, by Technique

  • 6.1. Separation Techniques
    • 6.1.1. Gas Chromatography (GC)
    • 6.1.2. Capillary Electrophoresis (CE)
    • 6.1.3. High Performance Liquid Chromatography (HPLC)
    • 6.1.4. Ultra Performance Liquid Chromatography (UPLC)
  • 6.2. Detection Techniques
    • 6.2.1. Nuclear Magnetic Resonance Spectroscopy (NMR)
    • 6.2.2. Mass Spectrometry (MS)
    • 6.2.3. Surface Based Mass Analysis

7. Metabolomics Market, by Application

  • 7.1. Biomarker Discovery
  • 7.2. Drug Discovery/Drug Assessment
  • 7.3. Toxicology Testing
  • 7.4. Nutrigenomics
  • 7.5. Others

8. Metabolomics Market, by Indication

  • 8.1. Oncology
  • 8.2. Cardiology
  • 8.3. Neurology
  • 8.4. Others

9. Metabolomics Market, by Geography

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Spain
    • 9.2.5. Italy
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. Japan
    • 9.3.2. China
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of the World (RoW)
    • 9.4.1. Latin America
    • 9.4.2. Middle East

10. Competitive Landscape

  • 10.1. New Product Launches
  • 10.2. Agreements/Partnerships/Collaborations/Joint Ventures
  • 10.3. Mergers and Acquisitions
  • 10.4. Other Developments

11. Company Profiles

  • 11.1. Agilent Technologies
    • 11.1.1. Business Overview
    • 11.1.2. Products & Services
    • 11.1.3. Key Financials
    • 11.1.4. Growth Strategy
    • 11.1.5. Recent Developments
    • 11.1.6. SWOT Analysis
    • 11.1.7. MNM View
  • 11.2. Biocrates Life Sciences AG
  • 11.3. Bruker Corporation
  • 11.4. Danaher Corporation
  • 11.5. Human Metabolomics Technologies, Inc.
  • 11.6. LECO Corporation
  • 11.7. Metabolon, Inc.
  • 11.8. Shimadzu Corporation
  • 11.9. Thermo Fisher Scientific Inc (Life Technologies + Prionics AG)
  • 11.10. Waters Corporation

List of Tables

  • Table 1: Global Metabolomics Market, By Technique Market , by Geography, 2012-2019 ($Million)
  • Table 2: Global Metabolomics Seperation technique Market , by Technique, 2012-2019 ($Million)
  • Table 3: Global Metabolomics Separation technique Market , by Geography, 2012-2019 ($Million)
  • Table 4: Global Metabolomics Detection technique Market , by Geography, 2012-2019 ($Million)
  • Table 5: Global Gas Chromatography Market , by Geography, 2012-2019 ($Million)
  • Table 6: Global Capillary Electrophoresis Market , by Geography, 2012-2019 ($Million)
  • Table 7: Global High Performance liquid chromatography Market , by Geography, 2012-2019 ($Million)
  • Table 8: Global Ultra performance liquid chromatography Market , by Geography, 2012-2019 ($Million)
  • Table 9: Global Nuclear Magnetic Resonance Spectroscopy Market , by Geography, 2011-2018 ($Million)
  • Table 10: Global Mass Spectrometry Market, by Geography, 2012-2019 ($Million)
  • Table 11: Global Surface Based Mass Analysis Market , by Geography, 2012-2019 ($Million)
  • Table 12: Global Metabolomics Market , by Indication, 2012-2019 ($Million)
  • Table 13: Global Metabolomics Oncology Market , by Geography, 2012-2019 ($Million)
  • Table 14: Global Metabolomics Cardiology Market , by geography, 2012-2019 ($Million)
  • Table 15: Global Metabolomics Neurology Market , by Geography, 2012-2019 ($Million)
  • Table 16: Global Metabolomics Other Indications Market , by Geography, 2012-2019 ($Million)
  • Table 17: Global Metabolomics Market , by application, 2012-2019 ($Million)
  • Table 18: Global Metabolomics Biomarker Discovery Market , by Geography, 2012-2019 ($Million)
  • Table 19: Global Metabolomics Drug Discovery Market , by geography, 2012-2019 ($Million)
  • Table 20: Global Metabolomics Toxicology Testing Market , by Geography, 2012-2019 ($Million)
  • Table 21: Global Metabolomics Mutrigenomics Market , by Geography, 2012-2019 ($Million)
  • Table 22: Global Metabolomics Other Applications Market , by Geography, 2012-2019 ($Million)
  • Table 23: North America: Metabolomics Market, By Country , 2012-2019 ($Million)
  • Table 24: North America: Metabolomics Market, By technique, 2012-2019 ($Million)
  • Table 25: North America: Market, By application, 2012-2019 ($Million)
  • Table 26: North America: Metabolomics Market, By indication, 2012-2019 ($Million)
  • Table 27: U.S.: Metabolomics Market, By Technique, 2012-2019 ($Million)
  • Table 28: U.S.: Market, By Application, 2012-2019 ($Million)
  • Table 29: U.S.: Metabolomics Market, By Indication , 2012-2019 ($Million)
  • Table 30: Canada: Metabolomics Market, By Technique, 2012-2019 ($Million)
  • Table 31: Canada: Market, By Application, 2012-2019 ($Million)
  • Table 32: Canada: Market, By Indication, 2012-2019 ($Million)
  • Table 33: Europe: Metabolomics Market, By Country , 2012-2019 ($Million)
  • Table 34: Europe: Market, By Technique , 2012-2019 ($Million)
  • Table 35: Europe: Market, By application, 2012-2019 ($Million)
  • Table 36: Europe: Market, By Indication, 2012-2019 ($Million)
  • Table 37: U.K.: Metabolomics Mrket, By technique , 2012-2019 ($Million)
  • Table 38: U.K.: Metabolomics Market, By Application, 2012-2019 ($Million)
  • Table 39: U.K.: Market, By Indication, 2012-2019 ($Million)
  • Table 40: Germany: Metabolomics Market, By technique , 2012-2019 ($Million)
  • Table 41: Germany: Market, By Application, 2012-2019 ($Million)
  • Table 42: Germany: Market, By Indication, 2012-2019 ($Million)
  • Table 43: France: Market, By Technique, 2012- 2019($Million)
  • Table 44: France: Metabolomics Market, By Application, 2012- 2019($Million)
  • Table 45: France: Metabolomics Market, By Indication , 2012- 2019($Million)
  • Table 46: Italy: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 47: Italy: Market, By Application , 2012- 2019($Million)
  • Table 48: Italy: Market, By Indication , 2012- 2019($Million)
  • Table 49: Spain: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 50: Spain: Market, By Application , 2012- 2019($Million)
  • Table 51: Spain: Market, By Indication , 2012- 2019($Million)
  • Table 52: ROE: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 53: ROE: Metabolomics Market, By Application , 2012- 2019($Million)
  • Table 54: ROE: Market, By Indication , 2012- 2019($Million)
  • Table 55: Asia_Pacific Metabolomics Market, By Country , 2012- 2019($Million)
  • Table 56: Asia_Pacific: Market, By Technique , 2012- 2019($Million)
  • Table 57: Asia_Pacific: Market, By Application , 2012- 2019($Million)
  • Table 58: Asia_Pacific: Metabolomics Market, By Indication , 2012- 2019($Million)
  • Table 59: Japan: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 60: Japan: Market, By Application , 2012- 2019($Million)
  • Table 61: Japan: Market, By Indication , 2012- 2019($Million)
  • Table 62: China: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 63: China: Market, By Application , 2012- 2019($Million)
  • Table 64: China: Metabolomics Market, By Indication , 2012- 2019($Million)
  • Table 65: India: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 66: India: Market, By Application , 2012- 2019($Million)
  • Table 67: India: Market, By Indication , 2012- 2019($Million)
  • Table 68: RoAPAC: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 69: RoAPAC: Metabolomics Market, By Application , 2012- 2019($Million)
  • Table 70: RoAPAC: Market, By Indication , 2012- 2019($Million)
  • Table 71: RoW: Metabolomics Market, By Country , 2012- 2019($Million)
  • Table 72: RoW: Market, By Technique , 2012- 2019($Million)
  • Table 73: RoW: Market, By Application , 2012- 2019($Million)
  • Table 74: RoW: Market, By Indication , 2012- 2019($Million)
  • Table 75: Latin America: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 76: Latin America: Market, By Application , 2012- 2019($Million)
  • Table 77: Latin America: Market, By Indication , 2012- 2019($Million)
  • Table 78: Middle East: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 79: Middle East: Market, By Application , 2012- 2019($Million)
  • Table 80: Middle East: Market, By Indication , 2012- 2019($Million)

List of Figures

  • Figure 1: Research methodology
  • Figure 2: Market Size Estimation Methodology
  • Figure 3: DATA Triangulation Methodology
  • Figure 4: Global Metabolomics Technique Market, 2014 VS. 2019 ($Milliion)
  • Figure 5: Global Market for Companion Animals, 2013 VS. 2018 ($Milliion)
  • Figure 6: Metabolomics Market: High-Growth Markets, 2013
  • Figure 7: Market Dynamics of Global Market
Back to Top